Home
About
FAQ
History (7)
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Usnea
Ziziphus
Impact of an 8-Year Intensive Lifestyle Intervention on an Index of Multimorbidity.
end date
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overview
researcher role of
Adams, Meredith
contributes to
Identifying Opioid Response Phenotypes in Low Back Pain Electronic Health Data